Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-07-12

Clinical Trial Update: Ginkgo Biloba Extract for Schizophrenia [NA]

View source ↗

Summary

The document reports that a clinical trial evaluating ginkgo biloba extract for schizophrenia has completed. No results are provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ginkgo biloba extract (Ginkgo biloba extract)

Snippet

Sponsor: Beijing HuiLongGuan Hospital | Conditions: Schizophrenia | NA | Status: COMPLETED